[go: up one dir, main page]

AU2001245647A1 - Antibodies that bind phosphatidyl serine and a method of their use - Google Patents

Antibodies that bind phosphatidyl serine and a method of their use

Info

Publication number
AU2001245647A1
AU2001245647A1 AU2001245647A AU4564701A AU2001245647A1 AU 2001245647 A1 AU2001245647 A1 AU 2001245647A1 AU 2001245647 A AU2001245647 A AU 2001245647A AU 4564701 A AU4564701 A AU 4564701A AU 2001245647 A1 AU2001245647 A1 AU 2001245647A1
Authority
AU
Australia
Prior art keywords
antibodies
phosphatidyl serine
bind
bind phosphatidyl
serine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245647A
Inventor
Peter Brams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idec Pharmaceuticals Corp
Original Assignee
Idec Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idec Pharmaceuticals Corp filed Critical Idec Pharmaceuticals Corp
Publication of AU2001245647A1 publication Critical patent/AU2001245647A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001245647A 2000-03-14 2001-03-14 Antibodies that bind phosphatidyl serine and a method of their use Abandoned AU2001245647A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18905000P 2000-03-14 2000-03-14
US60189050 2000-03-14
PCT/US2001/007895 WO2001068709A1 (en) 2000-03-14 2001-03-14 Antibodies that bind phosphatidyl serine and a method of their use

Publications (1)

Publication Number Publication Date
AU2001245647A1 true AU2001245647A1 (en) 2001-09-24

Family

ID=22695694

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245647A Abandoned AU2001245647A1 (en) 2000-03-14 2001-03-14 Antibodies that bind phosphatidyl serine and a method of their use

Country Status (3)

Country Link
US (1) US20020025319A1 (en)
AU (1) AU2001245647A1 (en)
WO (1) WO2001068709A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300308B1 (en) * 1997-12-31 2001-10-09 Board Of Regents, The University Of Texas System Methods and compositions for inducing autoimmunity in the treatment of cancers
US6818213B1 (en) * 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
CA2331789C (en) 1998-07-13 2013-09-10 Board Of Regents, The University Of Texas System Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
BR9911882A (en) 1998-07-13 2005-02-15 Univ Texas Cancer treatment process employing aminophospholipid antibodies
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
WO2003028840A2 (en) * 2001-09-27 2003-04-10 Board Of Regents, The University Of Texas System Combined compositions and methods for tumor vasculature coagulation and treatment
US7879801B2 (en) * 2002-07-15 2011-02-01 Board Of Regents, The University Of Texas System Compositions comprising cell-impermeant duramycin derivatives
US7714109B2 (en) 2002-07-15 2010-05-11 Board Of Regents, The University Of Texas System Combinations and kits for cancer treatment using selected antibodies to aminophospholipids
US7790159B2 (en) 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US7247303B2 (en) * 2002-07-15 2007-07-24 Board Of Regents, The University Of Texas System Selected antibody CDRs for binding to aminophospholipids
US7455833B2 (en) 2002-07-15 2008-11-25 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7615223B2 (en) * 2002-07-15 2009-11-10 Board Of Regents, The University Of Texas System Selected immunoconjugates for binding to aminophospholipids
US7678386B2 (en) 2002-07-15 2010-03-16 Board Of Regents The University Of Texas Liposomes coated with selected antibodies that bind to aminophospholipids
US7611704B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US20040131622A1 (en) * 2002-07-15 2004-07-08 Board Of Regents Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids
US7511124B2 (en) * 2002-07-15 2009-03-31 Board Of Regents, The University Of Texas System Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents
US7906115B2 (en) * 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7378386B2 (en) 2002-07-15 2008-05-27 Board Of Regents, The University Of Texas System Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives
US7572448B2 (en) * 2002-07-15 2009-08-11 Board Of Regents, The University Of Texas System Combined cancer treatment methods using selected antibodies to aminophospholipids
US7384909B2 (en) 2002-07-15 2008-06-10 Board Of Regents, The University Of Texas System Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
US7625563B2 (en) 2002-07-15 2009-12-01 Board Of Regents, The University Of Texas System Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids
KR20110025885A (en) 2002-07-15 2011-03-11 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 Peptides that bind to phosphatidylethanolamine and their use in treating viral infections
US7622118B2 (en) 2002-07-15 2009-11-24 Board Of Regents, The University Of Texas System Cancer treatment methods using selected antibodies to aminophospholipids
WO2008043018A1 (en) 2006-10-04 2008-04-10 Dana-Farber Cancer Institute, Inc. Tumor immunity
US20200055917A1 (en) 2016-09-27 2020-02-20 Cero Therapeutics, Inc. Chimeric engulfment receptor molecules
JP2020506904A (en) 2017-01-27 2020-03-05 シグナルアールエックス ファーマシューティカルズ，インコーポレイテッド Thienopyranones and furanopyranones as kinases, bromodomains and checkpoint inhibitors
FI3688032T3 (en) 2017-09-26 2025-12-09 Cero Therapeutics Holdings Inc CHIMERIC INVASIVE RECEPTOR MOLECULES AND METHODS OF USE
AU2019243154A1 (en) 2018-03-28 2020-10-01 Cero Therapeutics, Inc. Cellular immunotherapy compositions and uses thereof
EP3774906A1 (en) 2018-03-28 2021-02-17 Cero Therapeutics, Inc. Chimeric tim4 receptors and uses thereof
US20250339571A1 (en) * 2021-08-27 2025-11-06 Actinium Pharmaceuticals, Inc. Radioimmunoconjugates targeting phosphatidylserine for use in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800077D0 (en) * 1988-01-05 1988-02-10 Ciba Geigy Ag Novel chimeric antibodies

Also Published As

Publication number Publication date
WO2001068709A1 (en) 2001-09-20
US20020025319A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU2001245647A1 (en) Antibodies that bind phosphatidyl serine and a method of their use
AU2001275474A1 (en) Materials and methods for the control of nematodes
EP1211169A3 (en) Resilient crawler and method of manufacturing the same
AU2001251358A1 (en) Prion-binding ligands and methods of using same
AU2001265390A1 (en) Method of making electronic materials
AU2001259100A1 (en) Joint compound and method of making same
AU2001294175A1 (en) Method of purifying antibody
AU2002364528A1 (en) Bio-implant and method of making the same
AU2002248236A1 (en) Method of forming nano-crystalline particles and produrct formed thereof
AU2001280599A1 (en) Compounds and methods
AU2001257075A1 (en) Screen and method of making the same
AU2002340167A1 (en) Anti-hla-dr antibodies and the methods of using thereof
AU2001253418A1 (en) Compounds and methods
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001243394A1 (en) Compounds and methods
AU2001254936A1 (en) Method of reinforcing structures
AU3439001A (en) Gypsum wallboard and method of making same
AU2001274682A1 (en) A structural joint and means for the use of same
AUPQ872300A0 (en) Compounds and methods
AU2002228801A1 (en) Post-crepe stabilized material and method of producing the same
AU2002318925A1 (en) Multi-colored materials and method of making same
AU2002361718A1 (en) Oxidized fungal antigens and methods of making and using thereof
AU2001228628A1 (en) Stent-graft assembly and method of making the same
AU6028498A (en) Concrete pipes and methods for the manufacture thereof
AU2002237253A1 (en) Biosensor and method of producing the same